Home › CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research
 

Keywords :   


CombiMatrix Corp (CBMX) Receives "Buy" Rating from Zacks Investment Research

2016-02-21 21:23:01| Biotech - Topix.net

's stock had its "buy" rating reissued by Zacks Investment Research in a research note issued on Sunday, MarketBeat Ratings reports. They currently have a $20.00 price target on the stock.

Tags: buy research rating investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »